4.4 Article

Hypomethylation of the 14-3-3σ Promoter Leads to Increased Expression in Non-Small Cell Lung Cancer

Journal

GENES CHROMOSOMES & CANCER
Volume 50, Issue 10, Pages 830-836

Publisher

WILEY-BLACKWELL
DOI: 10.1002/gcc.20904

Keywords

-

Funding

  1. NIH [CA107510]
  2. Cancer Center [5P30 CA023074]

Ask authors/readers for more resources

The 14-3-3 proteins are a set of seven highly conserved proteins that have recently been implicated in having a role in human tumorigenesis. However, the mechanism by which 14-3-3 proteins may act in this capacity is not well understood. In this study, we examined the expression of one of the 14-3-3 family members, 14-3-3 sigma, since it was shown previously to be aberrantly altered in human tumors. Using quantitative rtPCR and immunohistochemistry, we found that the expression levels of 14-3-3 sigma were elevated in the majority of human non-small cell lung cancers (NSCLC) we examined. Surprisingly, we found that the 14-3-3 sigma gene was hypomethylated in lung tumors relative to normal lung tissue suggesting that decreased DNA methylation resulted in increased expression of 14-3-3 sigma in NSCLC. We also determined the gene copy number for 14-3-3 sigma in tumor samples and found no significant correlation with elevated mRNA expression. And also no mutations were found in 14-3-3 sigma gene. Overall, our data suggest that misregulated expression of 14-3-3 sigma gene may be due to altered methylation status. (C) 2011 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available